Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taclonex Gel in Extensive Psoriasis Vulgaris
NCT01229098Phase 2Completed
- Sponsor
- LEO Pharma
- Start
- Oct 2010
- Primary completion
- Sep 2011
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Taclonex + Hydrogel Patch in Psoriasis vulgaris (PV), sponsored by LEO Pharma. Started Oct 2010; status: completed.
02
Drugs
Taclonex + Hydrogel Patch
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT01229098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01229098.